Pharmaceutical and Medical Devices
Lai Li is a seasoned pharmaceutical executive and global business leader with over 20 years of experience spanning Southeast Asia and Greater China. She is currently overseeing business development in Southeast Asia at Dou Yee Enterprises. Prior to this, she held regional leadership roles at MSD, including Managing Director for Singapore & Malaysia, Taiwan, and General Manager for China Vaccines.
Throughout her career, Lai Li has delivered outstanding commercial results, such as achieving over US$1B in sales for the Gardasil HPV vaccine in China and securing US$240M in sales in Singapore and Malaysia. She has built successful partnerships with government stakeholders and industry players, notably securing large-scale public contracts and immunisation plans across multiple countries. She also contributed to health policy development and advocacy as a board member of the Pharmaceutical Associations in both Malaysia and Taiwan.
A strategic and resilient leader, Lai Li is known for her financial acumen, people development, and ability to thrive in ambiguity. Lai Li participates in global dialogues with ministers and economists and actively mentors the next generation of leaders.
